R otavirus gastroenteritis remains a common cause of hospitalizations and clinic visits in developed countries and is associated with significant economic burden. In the United States, studies conducted almost a decade ago estimated that each year, rotavirus was responsible for more than 50,000 hospitalizations 1,2 and 500,000 outpatient and emergency department visits annually at a cost exceeding one billion U.S. dollars.
3 Because of this disease burden, a rotavirus vaccine was recommended for routine immunization of U.S. infants when it was licensed in 1998. 4 This vaccine was withdrawn the next year because of an association with intussusception.
5 However, new vaccines against rotavirus may be licensed and recommended for use in the United States in the next 2 years.
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Decisions on the introduction of new rotavirus vaccines will require more current estimates of the burden of rotavirus disease. The principal goal of a U.S. rotavirus immunization program will be to prevent hospitalizations for severe rotavirus gastroenteritis. Recent data from hospital-based studies in the United States, 9 Latin America 10 and Asia 11, 12 indicate that the fraction of gastroenteritis hospitalizations that are attributable to rotavirus among children under 5 years of age may be much higher than older studies used for deriving national estimates. 13 The National Hospital Discharge Survey (NHDS) has been used to monitor the occurrence of gastroenteritis-and rotavirus-associated hospitalizations since 1979, and it provides the opportunity to follow long-term (24 years) trends in disease using a single, stable source of surveillance data. 1, 2, 14 For the current study, we used NHDS data to update previous estimates of gastroenteritis-and rotavirusassociated hospitalizations that were provided previously for the periods 1979 -1992 and 1993-1995. 1,2,14 We also report an analysis of diarrheal-associated disease hospitalizations from 1993 (when rotavirus-specific diagnosis codes became available) through 2002 to reassess the need for a rotavirus vaccine and to determine trends in disease and age-, sex-and region-specific rates of rotavirus-associated hospitalizations.
MATERIALS AND METHODS
Hospitalization discharge records were obtained from the NHDS for 1993 through 2002.
15 NHDS data consist of a representative sample of patient discharge records obtained from short-stay, nonfederal, general and children's hospitals in the United States. for children Ͻ5 years of age with acute gastroenteritis or diarrhea listed as one of the diagnoses. Nationally representative estimates of diarrhea-associated hospitalizations were calculated using the NHDS weighting methodology. Individual identifiers are not available and a hospitalization was the unit of analysis.
